The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Contract Manufacturing
Contract Manufacturing
Analysis of FDA drug approvals indicates favorable longer-term trend for CDMOs
2025 was a strong year for drugs approved by the agency with record-high outsourcing penetration. Lonza, Thermo Fisher, and Catalent remain the leaders.
Feb. 5, 2026
Contract Manufacturing
Charles River to close cell therapy CDMO site in Maryland acquired in 2021
Feb. 4, 2026
Contract Manufacturing
Lonza’s Vacaville biologics site to deliver its full potential in the early 2030s
Jan. 29, 2026
Contract Manufacturing
Catalent to close cell therapy center in Belgium amid reported drop in production
Jan. 28, 2026
Contract Manufacturing
Siegfried expands US manufacturing footprint with acquisition of two facilities
Jan. 27, 2026
Contract Manufacturing
Samsung Biologics reports 30% revenue growth in 2025 driven by plant utilization
Jan. 23, 2026
Contract Manufacturing
Fujifilm’s modular, scalable manufacturing takes shape amid complex global supply chain
Jan. 20, 2026
Contract Manufacturing
JPM26: WuXi Biologics says it is poised for sustainable, high growth
Jan. 15, 2026
Contract Manufacturing
JPM26: Thermo Fisher’s pharma services business benefits from US reshoring
Jan. 14, 2026
Looking for Something?
Load More Content
